stockportfolio.pro
Neurocrine Biosciences, Inc. Gross Profit 2009–2025
Neurocrine Biosciences, Inc. (NBIX) annual gross profit by fiscal year, computed from SEC filings. Compound growth +19.6%/yr over 16 years.
| Fiscal year | Gross Profit | Gross margin | Change (YoY) |
|---|---|---|---|
| FY 2025 | $2.81B | 98.2% | +21.0% |
| FY 2024 | $2.32B | 98.6% | +25.7% |
| FY 2023 | $1.85B | 97.9% | +26.1% |
| FY 2022 | $1.47B | 98.4% | +30.9% |
| FY 2021 | $1.12B | 98.7% | +8.1% |
| FY 2020 | $1.04B | 99.0% | — |
| FY 2019 | — | — | — |
| FY 2018 | $446.31M | 98.9% | +178.3% |
| FY 2017 | $160.37M | 99.2% | — |
| FY 2016 | — | — | — |
| FY 2015 | — | — | — |
| FY 2014 | — | — | — |
| FY 2013 | — | — | — |
| FY 2012 | — | — | — |
| FY 2011 | — | — | — |
| FY 2010 | — | — | — |
| FY 2009 | — | — | — |
Source: Neurocrine Biosciences, Inc. SEC filings — income statement (10-K). Refreshed nightly.
See the full picture for Neurocrine Biosciences, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeNeurocrine Biosciences, Inc. — frequently asked questions
What is Neurocrine Biosciences, Inc.'s gross profit?
Neurocrine Biosciences, Inc. (NBIX) reported gross profit of $2.81B for fiscal year 2025, per its SEC filings.
How has Neurocrine Biosciences, Inc.'s gross profit changed over time?
Between fiscal 2009 and 2025, NBIX's gross profit grew at roughly 19.6% per year (compound annual rate), from $160.37M to $2.81B.
Where does this data come from?
Figures are computed from Neurocrine Biosciences, Inc.'s official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.